Breaking Down the Benefits and Risk of Co-Administration of COVID-19 and Flu Vaccines
Drug Topics
NOVEMBER 1, 2022
Help protect patients by giving them the facts about getting both shots at once to save them a trip and increase rates of vaccination.
Sat.Oct 29, 2022 - Fri.Nov 04, 2022
530 
Tips for tackling trial recruitment and retention woes in oncology
PharmaVoice
OCTOBER 31, 2022
How new tools are helping companies find and keep cancer patients in clinical studies.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Protecting treatment advances for National Breast Cancer Awareness Month
PhRMA
OCTOBER 31, 2022
Since the 1980s, October has been recognized as National Breast Cancer Awareness Month — an opportunity for us to unite as a community to honor those who have had breast cancer and raise awareness about progress biopharmaceutical researchers have made towards treating the disease.
Wearables Made for the Pharmaceutical Industry
Pharmacy Times
OCTOBER 31, 2022
Purpose-built assisted reality solutions help streamline processes and maintain regulatory compliance from the laboratory to the factory floor.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacists Challenged With Amoxicillin, Adderall Shortages
Drug Topics
NOVEMBER 4, 2022
Shortages are leaving patients in the lurch.
While DCTs get all the hype, some industry insiders say the future is a digital hybrid
PharmaVoice
NOVEMBER 1, 2022
Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Proof-of-Concept Study Shows Positive Results for Novel HIV Treatment
Pharmacy Times
NOVEMBER 3, 2022
Investigational broadly neutralizing antibody shows promise as potential as a first-in-class treatment option for HIV.
Flu Shots and Ischemic Stroke Risk in Older Adults
Drug Topics
NOVEMBER 2, 2022
Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.
The other ‘D’ in DE&I
PharmaVoice
NOVEMBER 4, 2022
How companies can work to include people with disabilities into broader equity aims.
Pfizer, BioNTech report bivalent Covid-19 booster more protective than original vaccine
STAT
NOVEMBER 4, 2022
New data from Pfizer and BioNTech on their bivalent Covid-19 vaccine suggests the updated product may be more protective against more recent Omicron subvariants than the original version of the vaccine, the companies said in a statement released Friday. The companies said the levels of neutralizing antibodies that target the BA.4 and BA.5 subvariants of the SARS-CoV-2 virus were four-fold higher in people aged 55 and older who received the bivalent booster than in similarly aged people who recei
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic
Pharmacy Times
NOVEMBER 4, 2022
When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.
Science Communication Tips for Pharmacists
Drug Topics
NOVEMBER 3, 2022
Pharmacists can help educate patients as they try to analyze scientific information shared via the news or social media.
Acumen cruises into the fast lane with novel Alzheimer’s treatment
PharmaVoice
NOVEMBER 3, 2022
The company’s distinct amyloid-beta target, which just won a fast track designation, could give it an edge over the competition.
Opinion: How the world can end Covid-19 as a public health threat
STAT
NOVEMBER 3, 2022
The journal Nature published today global consensus recommendations to end Covid-19 as a public health threat. It took a panel of almost 400 independent-thinking scientists, doctors, and representatives of community groups from more than 100 countries (we were among the co-chairs) some 14 months to develop and agree on these recommendations. There have been times when we wondered if it was worth the effort.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Social Isolation May Be Associated with Worse Outcomes in Heart Failure Patients
Pharmacy Times
NOVEMBER 4, 2022
Among heart failure patients, those who were at risk of social isolation had a worse attitude about advance care planning.
What Do the Midterms Mean for Pharmacy?
Drug Topics
NOVEMBER 3, 2022
Independent pharmacists stand to gain—or lose—depending on what happens at the polls in November 2022.
Woman of the Week: City of Hope’s Gulden Mesara
PharmaVoice
NOVEMBER 2, 2022
Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.
Verge Genomics takes AI-sourced drug for ALS into clinic
pharmaphorum
OCTOBER 31, 2022
Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
If You Want to Know Where Pharmacists' Roles Are Heading, Follow Patients
Pharmacy Times
OCTOBER 31, 2022
Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Crisis (Not) Averted
Drug Topics
NOVEMBER 2, 2022
It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.
Tuberculosis patients haven’t seen new treatments in 40 years – now Merck and Gates MRI have teamed up to change that
PharmaVoice
NOVEMBER 1, 2022
The Bill & Melinda Gates Medical Research Institute’s clinical development leader talks about its new licensing deal with Merck.
Could digital therapeutics provide a solution against opioid abuse?
pharmaphorum
NOVEMBER 2, 2022
Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition. The struggle to manage pain for individuals has been one that goes back a long way in history, with one of the earliest recorded medical prescriptions being for opium.
Study Links Vaping With Reduced Cardiovascular Function
Pharmacy Times
NOVEMBER 3, 2022
Among nicotine users, there was an approximately 4 beat per minute jump in heart rate after vaping or smoking.
New Pneumococcal Vaccine Shows Promise in Preventing Disease In Adults
Drug Topics
NOVEMBER 1, 2022
Phase I/II data indicate that new investigative pneumococcal conjugate vaccine shows efficacy in preventing disease in adults.
‘Zombie’ cells, Shkreli and cats — new research in toxoplasmosis and how the three are connected
PharmaVoice
NOVEMBER 3, 2022
Toxoplasmosis is carried by about a third of the world’s population, but effective drugs are lacking — now researchers have discovered a key infection element that could lead to better treatment.
Here’s why we’re not prepared for the next wave of biotech innovation
STAT
NOVEMBER 3, 2022
T he first time I remember hearing the words “biology’s century,” it was a sales pitch. I was standing by the Long Island Sound in Sachem’s Head, Conn., in the shadow of an 11-foot-tall granite Stonehenge replica built by Jonathan Rothberg, a biotech entrepreneur, as he talked up his newest gadget, a tabletop DNA sequencer.
Evolution of Pharmacist Role in Treatment and Management of Breast Cancer
Pharmacy Times
NOVEMBER 2, 2022
Dr Vinokurov illustrates the evolving role of pharmacists in HR+/HER2- breast cancer treatment.
Increased Scanning with CGM Improves Glucose Control in T1D
Drug Topics
OCTOBER 31, 2022
Research shows that an increase in intermittent scanning helps improve glycemic control and reduce the fear of hypoglycemia.
How does the Inflation Reduction Act affect healthcare?
PharmaVoice
OCTOBER 31, 2022
The Inflation Reduction Act helps support American families by lowering prescription drug prices and reducing overall healthcare costs.
“Universal” CRISPR-edited T cells improve resistant leukaemia
European Pharmaceutical Review
NOVEMBER 2, 2022
Researchers at Great Ormond Street Hospital for Children (GOSH) and University College London (UCL) Great Ormond Street Institute of Child Health (UCL GOS ICH) have used “universal” CRISPR-edited cells in humans for the first time to treat B-cell acute lymphoblastic leukaemia (B-ALL) child patients with engineered donor T cells. The treatment did not require matching donor cells, a major step in developing gene-edited cells for cancer treatment.
Respiratory Syncytial Virus Infection in the Pediatric Population
Pharmacy Times
NOVEMBER 4, 2022
Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.
The Vaccine That Prevents Cancer
Drug Topics
NOVEMBER 3, 2022
Human papillomavirus vaccines can help prevent cancern, but uptake still lags.
How Europe’s energy crisis is impacting pharma
PharmaVoice
NOVEMBER 2, 2022
Inflationary pressures and rising energy costs could further expedite the movement of generics manufacturing from Europe to Asia if governments don’t step in.
Let's personalize your content